Current Hematologic Malignancy Reports

雜志介紹

Current Hematologic Malignancy Reports雜志介紹

《Current Hematologic Malignancy Reports》是一本以English為主的未開放獲取國際優秀期刊，中文名稱當前血液系統惡性腫瘤報告，本刊主要出版、報道醫學-HEMATOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.7，最新CiteScore 指數為6。

本刊近期中國學者發表的論文主要有：

• Hairy Cell Leukemia—New Genes, New Targets

  Author: Robert J. Kreitman

• Management of Advanced NK/T-Cell Lymphoma

  Author: Eric Tse, Yok-Lam Kwong

• Immunologic Milieu of Mature T-Cell and NK-Cell Lymphomas—Implications for Therapy

  Author: Eric Tse, Yok-Lam Kwong

英文介紹

Current Hematologic Malignancy Reports雜志英文介紹

his journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hematologic malignancy.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as leukemia, lymphoma, myeloma, and T-cell and other lymphoproliferative malignancies. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.